Hua Medicine (Shanghai) Ltd. (HKG:2552)
Hong Kong
· Delayed Price · Currency is HKD 2.090
+0.030 (1.46%)
May 16, 2025, 4:08 PM HKT
Hua Medicine (Shanghai) Revenue
In the year 2024, Hua Medicine (Shanghai) had annual revenue of 255.89M CNY with 234.02% growth. Hua Medicine (Shanghai) had revenue of 153.23M in the half year ending December 31, 2024, with 770.67% growth.
Revenue
255.89M CNY
Revenue Growth
+234.02%
P/S Ratio
7.55
Revenue / Employee
1.52M CNY
Employees
168
Market Cap
2.06B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeiGene | 32.53B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| WuXi Biologics | 19.87B |
| Alibaba Health Information Technology | 31.39B |
| Innovent Biologics | 10.03B |
| Akeso | 2.26B |
| Sino Biopharmaceutical | 30.72B |